Physician profile
Sung Yang
NPI 1780819615
$1,566.59
in general payments reported to CMS, 2019-2025
15 companies · $575 in 2025
The $575 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $129 · 2022: $83.65 · 2023: $85.49 · 2024: $118 · 2025: $575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $778.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $415.92 | 2019 | |
| W. L. Gore & Associates, INC. | $265.08 | 2019-2020 | |
| Medtronic, INC. | $172.19 | 2024-2025 | Endurant Iis |
| Shape Memory Medical INC. | $135.00 | 2025 | Impede Embolization Plug |
| Reflow Medical INC | $120.00 | 2025 | |
| Bolton Medical INC | $85.62 | 2025 | |
| Lemaitre Vascular, INC. | $74.12 | 2023-2025 | Artegraft Vascular Graft, Restoreflow |
| Janssen Pharmaceuticals, INC | $70.46 | 2019-2024 | Xarelto |
| Kerecis Limited | $59.10 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Stryker Corporation | $50.23 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $43.77 | 2022-2023 | |
| Sanara Medtech INC. | $19.90 | 2024 | Celleraterx |
| Organogenesis INC. | $19.25 | 2024 | |
| Solventum Corporation | $18.95 | 2025 | V.A.C. Veraflo Cleanse Choice, V.A.C. Veraflo, V.A.C.Ulta |
| Cagent Vascular INC | $17.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sung Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.